US Patent 11377467 Crystalline form of gemcitabine

Patent 11377467 was granted and assigned to NuCana on July, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

NuCana

Current Assignee

NuCana

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

113774670

Patent Inventor Names

Hugh Griffith0

Date of Patent

July 5, 2022

Patent Application Number

160653690

Date Filed

December 21, 2016

Patent Citations

‌

US Patent 10117888 Formulation comprising a gemcitabine-prodrug

‌

US Patent 10005810 Process for preparing nucleoside prodrugs

Patent Primary Examiner

‌

Layla D Berry

This invention relates to a crystalline form of gemcitabine-[phenyl-(benzoxy-L-alaninyl)]-(S)-phosphate.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11377467 Crystalline form of gemcitabine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API